In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Twinstrand Therapeutics Inc.

Division of Emergent BioSolutions Inc.
www.twinstrand.com

Latest From Twinstrand Therapeutics Inc.

Cangene acquires Twinstrand Therapeutics

Cangene has acquired privately held Twinstrand Therapeutics for Cdn$1.5 million ($1.3 million). The deal brings in products, technologies and financial attributes, said Cangene.

Deals
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Emergent BioSolutions Inc.
  • Senior Management
  • Contact Info
  • Twinstrand Therapeutics Inc.
    Phone: (604) 415-7180
    8081 Lougheed Hwy.
    Burnaby, V5A 1W9
    Canada
Advertisement
Advertisement
UsernamePublicRestriction

Register